About us
Platform
Pipeline
Overview
Azelaprag (BGE-105)
BGE-100
Resources
Press releases
In the news
Events
Publications
Presentations
Podcast
Careers
Publications & background
Publications on our programs and background literature on our approach and targets
azelaprag
(Apelin / APJ)
BGE-100
(NLRP3)
platform
aging
Azelaprag publications
Apelin in metabolism
Mouse genetics
BioAge NLRP3 inhibitors
NLRP3 as a longevity target
NLRP3 in obesity
Cardiovascular Drugs and Therapy
August 2023
A First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients
August 2023
JCI Insight
April 2020
Cardiovascular response to small-molecule APJ activation
April 2020
Home
About us
Platform
Pipeline
Overview
Azelaprag (BGE-105)
BGE-100
Resources
Press releases
In the news
Events
Publications
Presentations
Podcast
Careers
